Perifosine: all 37 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT01051557Phase 1/2Results posted
- Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT00873457Phase 2Results posted
- Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant GliomasCompletedNCT00590954Phase 2Results posted
- Perifosine in Patients With Relapsed/Refractory Waldenstrom's MacroglobulinemiaCompletedNCT00422656Phase 2Results posted
- Perifosine in Treating Patients With Recurrent Prostate CancerTerminatedNCT00058214Phase 2Results posted
- A Food Effect and QTc Study of Perifosine in Patients With Advanced MalignanciesCompletedNCT01224730Phase 1
- Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal CancerCompletedNCT01097018Phase 3
- Perifosine With Temsirolimus for Recurrent Pediatric Solid TumorsCompletedNCT01049841Phase 1
- Study of Perifosine + Capecitabine for Colon Cancer PatientsCompletedNCT01048580Phase 1
- Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma PatientsTerminatedNCT01002248Phase 3
- Study of Single Agent Perifosine for Recurrent Pediatric Solid TumorsCompletedNCT00776867Phase 1
- Ph II Study of Perifosine for Patients With Carcinoma of the KidneyCompletedNCT00498966Phase 2
- Ph II Study of Perifosine Plus Gleevec for Patients With GISTCompletedNCT00455559Phase 2
- A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal CancerCompletedNCT00448721Phase 2
- Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian CancerCompletedNCT00431054Phase 1
- Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple MyelomaCompletedNCT00415064Phase 1
- A Trial of Perifosine in Patients With Chemo-Insensitive SarcomasCompletedNCT00401388Phase 2
- A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung CancerCompletedNCT00399789Phase 1/2
- Perifosine + Sunitinib Malate for Patients With Advanced CancersCompletedNCT00399152Phase 1
- Phase I Trial of Paclitaxel With PerifosineCompletedNCT00399126Phase 1
- Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer PatientsCompletedNCT00398879Phase 2
- Phase I Study of Perifosine + Sorafenib for Patients With Advanced CancersCompletedNCT00398814Phase 1
- A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's MacroglobulinemiaCompletedNCT00398710Phase 2
- Phase I Perifosine and Gemcitabine StudyCompletedNCT00398697Phase 1
- Phase II Study of Perifosine in Patients With Refractory and Relapsed LeukemiaCompletedNCT00391560Phase 2
- Trial of Two Schedules of Perifosine for Patients With Solid Tumors or LymphomasCompletedNCT00389077Phase 2
- 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic SyndromesCompletedNCT00301938Phase 1
- Perifosine in Treating Patients With Advanced Soft Tissue SarcomaCompletedNCT00064324Phase 2
- Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck CancerTerminatedNCT00062387Phase 2
- Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate CancerCompletedNCT00060437Phase 2
- Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00059982Phase 2
- Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast CancerCompletedNCT00054145Phase 2
- Perifosine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00053924Phase 2
- Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaCompletedNCT00053794Phase 2
- Perifosine in Treating Patients With Metastatic or Recurrent Malignant MelanomaCompletedNCT00053781Phase 2
- Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerCompletedNCT00019656Phase 1
- Perifosine in Treating Patients With Advanced Solid TumorsCompletedNCT00005794Phase 1